Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Adlai Nortye
View:
Post by fox7mf on Apr 18, 2021 7:50am

Adlai Nortye

is indeed entering P3 (breast cancer) using Pela. Check Adlai website under 'pipeline.'
Comment by askretka on Apr 19, 2021 2:02pm
I've been on the Website and seen that chart. I don't think Phase 3 has started. There should be an announcement somewhere and I think Oncolytics would get another milestone payment? I'm pretty sure they were waiting for Aware data first.
Comment by stayhumble1 on Apr 19, 2021 2:23pm
That is also my understanding Askretka re: Adlai Nortye's Ph3 not having yet begun. As per Adlai's news release Mar 21/2019 concerning their plans for a Ph3 trial: We will launch the clinical trial to join our global partner Oncolytics Biotech Inc. when they initiate their phase III registration study. We will continue to bring more options to cancer patients."
Comment by JohnnyYeg on Apr 19, 2021 4:14pm
I honestly can't remember the last time Coffey spoke the words "Adlai" or "Nortye" in a conference call or presentation. Are they even relevant anymore?
Comment by askretka on Apr 21, 2021 10:56am
Might still be relevant. Breast cancer is #1 in new cancers worldwide according to WHO 2020 That kind of surprised me. Numbers of women in China are higher % wise too. ---------- What's behind the huge increase in breast cancer rates in China? Link. https://www.google.com/amp/s/theconversation.com/amp/whats-behind-the-huge-increase-in-breast-cancer-rates-in-china-84224 ------------------------ ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities